EMV Capital (AIM:EMVC), the venture capital group focused on deep-tech and life sciences, has announced plans to raise up to £1.5 million through a subscription and retail offer of new shares.
Stock will be issued at 50p, a 15% premium over the closing price of 43.5p.
The fundraising will allow EMV to expand its investment portfolio in transformative technologies globally.
Specifically, the new funds, combined with the company’s fee income, will be allocated over the next 12 months to ensure operational efficiency and drive value creation.
Key areas of focus include supporting day-to-day operations through working capital and enhancing investor reporting systems for EMV Capital (AIM:EMVC) Partners, its corporate finance and venture capital arm.
These improvements aim to accommodate the growing base of syndicated investors and fund management activities.
The company also intends to expand its team with key hires, bolstering operational and strategic capabilities.
Additionally, part of the funds will be used to strengthen the balance sheet and maintain flexibility for capital-efficient investments, with an emphasis on its venture-building initiatives.